For investing in Venom, one issue ticks both the durability and liquidity boxes: Amazing Spider-Man #300 (first full appearance, May 1988), with a €529 eBay median and 101 active listings (June 2026), plus a documented record sale of $13,500 in high grade. The rest of the symbiote family is cheaper but riskier. Here are the real values, the actual liquidity, and the pitfalls — with no invented return figures.
Venom debuted in 1988: there's no Silver Age here, it's a Copper/Modern Age character. Its values were lifted by Sony's trilogy ($1.84B worldwide box office, source Box Office Mojo), which widened the buyer base. But "popular character" doesn't mean "good investment": the gap between issues is enormous.
This guide uses verifiable data only: live eBay values (our estimator) and documented records. No past return figure is invented — when a data point can't be verified, we state it qualitatively. This is not financial advice.
Venom issues and their real value (June 2026)
Values = median of active eBay listings, all editions and grades combined (our estimator, eBay.fr + eBay.com). The listing count is the key metric: it's liquidity — how easily you can resell.
| Issue | Significance | eBay median | Liquidity |
|---|---|---|---|
| ASM #300 (1988) | First full Venom appearance | €529 | 101 listings |
| ASM #252 (1984) | First black suit (Earth-616) | €244 | 99 listings |
| ASM #316 (1989) | First full Venom cover | €208 | 100 listings |
| ASM #361 (1992) | First Carnage appearance | €115 | 101 listings |
| ASM #362 (1992) | Second Carnage, direct follow-up | €20 | 101 listings |
Liquidity: the most underrated criterion
A comic only has "value" if you can resell it. Every issue above shows ~100 active listings at any given time: a deep, liquid market, rare for 1988-1992 issues. In practice, you'll always find a buyer — and a reference price — without locking up your capital for months.
Careful, though: high liquidity also means high supply. Nobody holds absolute scarcity on these raw issues. The value lever is condition, not the issue number alone.
Why condition makes all the difference
The "all grades combined" median for ASM #300 (€529) is pulled down by raw copies and lots. The documented record for this issue in high grade is $13,500 (sources: GoCollect, QualityComix). The gap between a creased copy and a CGC 9.8 runs into thousands of euros. Investing in Venom means, above all, investing in the grade. An average raw copy isn't an investment — it's a collectible.
The concrete risks
- 1990s oversupply. Venom is a modern character: print runs were huge. Venom: Lethal Protector #1 (1993, first solo series) has ~24,000 copies already CGC-certified, of which ~10,000 in grade 9.8 (source: GoCollect). The 9.8 is almost a baseline there, not a rarity — hence a modest value (NM- ~$55 Overstreet). This issue isn't indexed by our eBay estimator (limited to Amazing Spider-Man): check it case by case.
- Dependence on the film calendar. Mainstream demand tracks the movies. Sony's trilogy ended (2024) — without a new project, the momentum can fade.
- Fakes and restoration. On a €500+ issue, CGC/CBCS certification isn't optional.
A grounded approach (based on real data)
- #300 in high grade = the safe haven. Maximum liquidity, durable demand, undisputed cornerstone status.
- #361 (Carnage) at ~€115 = the entry point. The first appearance of a major character, still affordable.
- Be wary of €20 issues (e.g. #362): fun to collect, but resale margin is near zero after fees.
- Check the value at the time you buy. The medians above are from June 2026; prices move.
Own a Venom comic? Get a free valuation with our tool based on real eBay sales to find its low, median and high value before you buy or sell.